Skip to main navigation Skip to search Skip to main content

Corrigendum: Epigallocatechin gallate decreases plasma triglyceride, blood pressure, and serum kisspeptin in obese human subjects (Experimental Biology and Medicine, (2021), 246, 2, (163-176), 10.1177/1535370220962708)

  • Saimai Chatree
  • , Chantacha Sitticharoon
  • , Pailin Maikaew
  • , Kitchaya Pongwattanapakin
  • , Issarawan Keadkraichaiwat
  • , Malika Churintaraphan
  • , Chanakarn Sripong
  • , Rungnapa Sririwichitchai
  • , Sompol Tapechum
  • Siriraj Hospital

Research output: Contribution to journalComment/debate

2 Citations (Scopus)

Abstract

In the published article, there is an error in the Certificate of Ethical Approval Number in the Ethics Statement. The published certificate of approval number was mistakenly stated as “si344/2558(EC2).” The correct number for the Certificate of Ethical Approval Number is “Si 563/2015”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Original languageEnglish
Article number10179
JournalExperimental Biology and Medicine
Volume249
DOIs
Publication statusPublished - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • blood pressure
  • epigallocatechin gallate
  • human adipocytes
  • kisspeptin
  • obesity
  • plasma triglyceride

Fingerprint

Dive into the research topics of 'Corrigendum: Epigallocatechin gallate decreases plasma triglyceride, blood pressure, and serum kisspeptin in obese human subjects (Experimental Biology and Medicine, (2021), 246, 2, (163-176), 10.1177/1535370220962708)'. Together they form a unique fingerprint.

Cite this